
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Genet. , 29 April 2021
Sec. RNA
Volume 12 - 2021 | https://doi.org/10.3389/fgene.2021.616220
This article is part of the Research Topic RNA Modification in Human Cancers: Roles and Therapeutic Implications View all 48 articles
A retraction of this article was approved in:
Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer
Citation: Jia X, Wei L and Zhang Z (2021) NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer. Front. Genet. 12:616220. doi: 10.3389/fgene.2021.616220
Received: 11 October 2020; Accepted: 27 January 2021;
Published: 29 April 2021; Retracted: 31 January 2022.
Edited by:
Jing Sun, George Washington University, United StatesReviewed by:
Haixiang Yu, Duke University, United StatesDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.